CMPX vs PYPL · $367.4M cap vs P/E 7.9, rev $33.17B
Compass Therapeutics Inc. (CMPX) versus PayPal Holdings Inc (PYPL) — a side-by-side from cached financials, not a winner call.
Compass Therapeutics Inc. (CMPX) is a biotechnology company listed on US.
PayPal Holdings Inc (PYPL) is a credit services company listed on NASDAQ. It is led by Alex Chriss.
CMPX does not have a complete income-statement cache yet.
Latest reported PYPL revenue for 2025-12-31 was $33.17B. Net income was $5.23B. Revenue was up 4.3% from 2024-12-31 to 2025-12-31. PYPL currently screens at market cap $37.12B and trailing P/E 7.9.
CMPX currently screens at market cap $367.4M. PYPL currently screens at market cap $37.12B and trailing P/E 7.9.
Not investment advice. Open the CMPX and PYPL stock pages for the full models.
Not investment advice.